Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Cashflows-From-Investing-Activities" stands at 5.14 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2024.
Johnson & Johnson's third quarter result of 0.788 Billion USD for the item "Other Cashflows From Investing Activities" represents a decrease of -43.63 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of 0.788 Billion USD for the item "Other Cashflows From Investing Activities" represents a decrease of -65.42 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 5.14 Billion USD for the item "Other Cashflows From Investing Activities" represents a decrease of -22.49 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.511 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.511 Billion United States Dollars.
The 3 year change is 11.83 Billion United States Dollars.
The 5 year change is 6.16 Billion United States Dollars.
The 10 year change is 5.63 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Cashflows From Investing Activities | 905,699,262,464.00 |
![]() | AbbVie Inc - Other Cashflows From Investing Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Cashflows From Investing Activities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Cashflows From Investing Activities | 280,205,508,085.11 |
![]() | Novartis AG - Other Cashflows From Investing Activities | 255,096,620,580.91 |